Point72 Asset Management
LVTX

Point72 Asset Management’s LAVA Therapeutics LVTX Stock Holding History

Point72 Asset Management’s Portfolio LVTX Stock Details LVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-111,993
Closed -$330K – 1669
2022
Q2 		$330K Sell
111,993
-4,988
-4% -$17.3K ﹤0.01% 1235
2022
Q1 		$515K Sell
116,981
-2,171
-2% -$11K ﹤0.01% 1013
2021
Q4 		$655K Sell
119,152
-4,759
-4% -$31.2K ﹤0.01% 947
2021
Q3 		$734K Buy
+123,911
New +$892K ﹤0.01% 893
2021
Q2 		– Sell
-5,561
Closed -$84K – 1102
2021
Q1 		$84K Buy
+5,561
New +$76.4K ﹤0.01% 909

Other funds holding LVTX

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.37B AUM 63.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return